Lifeway’s Independent Directors Support CEO Julie Smolyansky and Lifeway 2.0 Strategy
Lifeway Foods, Inc.
Tue, March 1, 2022, 12:30 PM·3 min read
Lifeway Foods, Inc.
MORTON GROVE, Ill., March 01, 2022 (GLOBE NEWSWIRE) -- Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today issued a response to the recent 13D filing. The independent Directors of the Board issued the following response:
“Lifeway’s independent Directors fully supports CEO Julie Smolyansky and her continued execution of the Lifeway 2.0 strategy. Julie has consistently delivered growth for the Lifeway brands during her tenure as CEO. We believe the Company is reaching an important inflection point supported by ongoing research around probiotics and their influence on gut health, mental health and immunity, all of which are especially important with the impact of Covid-19. Her execution of the Lifeway 2.0 strategy and transition into Lifeway 3.0 has already delivered significant results for our stockholders including eight consecutive quarters of year-over-year net sales increases. Further, we believe new product innovation with the recent introduction of Lifeway Oat, a probiotic cultured oat drinkable and the recent expansion into drinkable yogurt through the acquisition of GlenOaks Farms will drive future success and we look forward to continued growth under her leadership.”
As fiduciaries to stockholders, the Board of Directors will consider all ideas to deliver long term value.
“I am grateful and appreciate the Board’s support through these challenging times. My loyalty lies with our Company, our brand, our customers, our employees, our shareholders, and my father’s legacy,” said Lifeway CEO Julie Smolyansky.
<snip>
Lifeway’s Independent Directors Support CEO Julie Smolyansky and Lifeway 2.0 Strategy (yahoo.com) |
